journal
Journals Nanomedicine : Nanotechnology,...

Nanomedicine : Nanotechnology, Biology, and Medicine

https://read.qxmd.com/read/38579530/corrigendum-to-solid-state-nanopore-analysis-of-human-genomic-dna-shows-unaltered-global-5-hydroxymethylcytosine-content-associated-with-early-stage-breast-cancer-nanomed-nanotechnol-biol-med-35-2021-102407
#1
Osama K Zahid, Felipe Rivas, Fanny Wang, Komal Sethi, Katherine Reiss, Samuel Bearden, Adam R Hall
No abstract text is available yet for this article.
April 4, 2024: Nanomedicine: Nanotechnology, Biology, and Medicine
https://read.qxmd.com/read/38499167/quantitative-analysis-of-mrna-lipid-nanoparticle-stability-in-human-plasma-and-serum-by-size-exclusion-chromatography-coupled-with-dual-angle-light-scattering
#2
JOURNAL ARTICLE
Brian Liau, Li Zhang, Melgious Jin Yan Ang, Jian Yao Ng, C V Suresh Babu, Sonja Schneider, Ravindra Gudihal, Ki Hyun Bae, Yi Yan Yang
Understanding the stability of mRNA loaded lipid nanoparticles (mRNA-LNPs) is imperative for their clinical development. Herein, we propose the use of size-exclusion chromatography coupled with dual-angle light scattering (SEC-MALS) as a new approach to assessing mRNA-LNP stability in pure human serum and plasma. By applying a dual-column configuration to attenuate interference from plasma components, SEC-MALS was able to elucidate the degradation kinetics and physical property changes of mRNA-LNPs, which have not been observed accurately by conventional dynamic light scattering techniques...
March 16, 2024: Nanomedicine: Nanotechnology, Biology, and Medicine
https://read.qxmd.com/read/38484918/bioresponsive-nanocomplex-integrating-cancer-associated-fibroblast-deactivation-and-immunogenic-chemotherapy-for-rebuilding-immune-excluded-tumors
#3
JOURNAL ARTICLE
Lisha Liu, Beiyuan Zhang, Xianggui Wu, Gang Cheng, Xiaopeng Han, Xiaofei Xin, Chao Qin, Lei Yang, Meirong Huo, Lifang Yin
Cancer-associated fibroblasts (CAFs) play a crucial role in creating an immunosuppressive environment and remodeling the extracellular matrix within tumors, leading to chemotherapy resistance and limited immune cell infiltration. To address these challenges, integrating CAFs deactivation into immunogenic chemotherapy may represent a promising approach to the reversal of immune-excluded tumor. We developed a tumor-targeted nanomedicine called the glutathione-responsive nanocomplex (GNC). The GNC co-loaded dasatinib, a CAF inhibitor, and paclitaxel, a chemotherapeutic agent, to deactivate CAFs and enhance the effects of immunogenic chemotherapy...
March 12, 2024: Nanomedicine: Nanotechnology, Biology, and Medicine
https://read.qxmd.com/read/38460654/functionalization-and-magnetonavigation-of-t-lymphocytes-functionalized-via-nanocomposite-capsules-targeting-with-electromagnetic-tweezers
#4
JOURNAL ARTICLE
Anatolii Abalymov, Maxim A Kurochkin, Sergei German, Aleksei Komlev, Evgeny S Vavaev, Evgeny V Lyubin, Andrey A Fedyanin, Dmitry Gorin, Marina Novoselova
Modification of T-lymphocytes, which are capable of paracellular transmigration is a promising trend in modern personalized medicine. However, the delivery of required concentrations of functionalized T-cells to the target tissues remains a problem. We describe a novel method to functionalize T-cells with magnetic nanocapsules and target them with electromagnetic tweezers. T-cells were modified with the following magnetic capsules: Parg/DEX (150 nm), BSA/TA (300 nm), and BSA/TA (500 nm)...
March 7, 2024: Nanomedicine: Nanotechnology, Biology, and Medicine
https://read.qxmd.com/read/38460653/chemical-modification-of-bradykinin-polymer-conjugates-for-optimum-delivery-of-nanomedicines-to-tumors
#5
JOURNAL ARTICLE
Enoch Appiah, Hideaki Nakamura, Anthony Assumang, Tomáš Etrych, Mamoru Haratake
We recently prepared pH-responsive HPMA copolymer conjugates of bradykinin (P-BK), which release BK in response to the acidic tumor microenvironment, and found that administration of P-BK increased the tumor accumulation and therapeutic efficacy of nanomedicine. Because the release of BK from P-BK determines its onset of action, P-BKs with different release rates were prepared, and their properties were evaluated. The release kinetics were significantly altered by substitution proximal to hydrazone bond, release constant of methyl-substituted P-BK (P-MeBK) was approximately 4- and 80-fold higher than that of cyclopropyl-substituted P-BK (P-CPBK) and phenyl-substituted P-BK (P-PhBK)...
March 7, 2024: Nanomedicine: Nanotechnology, Biology, and Medicine
https://read.qxmd.com/read/38458368/m2-type-macrophage-targeted-delivery-of-ikk%C3%AE-sirna-induces-m2-to-m1-repolarization-for-cnv-gene-therapy
#6
JOURNAL ARTICLE
Yu Zhang, Baorui Chu, Qian Fan, Xian Song, Qian Xu, Yi Qu
Choroidal Neovascularization (CNV) is capable of inciting recurrent hemorrhage in the macular region, severely impairing patients' visual acuity. During the onset of CNV, infiltrating M2 macrophages play a crucial role in promoting angiogenesis. To control this disease, our study utilizes the RNA interference (RNAi)-based gene therapy to reprogram M2 macrophages to the M1 phenotype in CNV lesions. We synthesize the mannose-modified siRNA-loaded liposome specifically targeting M2 macrophages to inhibit the inhibitory kappa B kinase β (IKKβ) gene involved in the polarization of macrophages, consequently modulating macrophage polarization state...
March 6, 2024: Nanomedicine: Nanotechnology, Biology, and Medicine
https://read.qxmd.com/read/38341011/engineered-photonic-near-infrared-light-activated-photothermal-theranostic-nanovaccine-induced-targeted-remodeling-of-tumor-microenvironment
#7
JOURNAL ARTICLE
Karunanidhi Gowsalya, Babu Rithisa, Yuvaraj Haldorai, Krishnamurthy Shanthi, Raju Vivek
Tumor recurrence, which happens as a result of persisting tumor cells and minor lesions after treatments like surgery and chemotherapy, is a major problem in oncology. Herein, a strategy to combat this issue by utilize a theranostic nanovaccine composed of photonic HCuS. This nanovaccine aims to eradicate cancer cells and their traces while also preventing tumor recurrence via optimizing the photothermal immune impact. Successful membrane targeting allows for the introduction of new therapeutic agents into the tumor cells...
February 8, 2024: Nanomedicine: Nanotechnology, Biology, and Medicine
https://read.qxmd.com/read/38341010/ft-raman-spectra-in-combination-with-machine-learning-and-multivariate-analyses-as-a-diagnostic-tool-in-brain-tumors
#8
JOURNAL ARTICLE
Bartłomiej Tołpa, Wiesław Paja, Elżbieta Trojnar, Kornelia Łach, Agnieszka Gala-Błądzińska, Aneta Kowal, Ewelina Gumbarewicz, Paulina Frączek, Jozef Cebulsk, Joanna Depciuch
Brain tumors are one of the most dangerous, because the position of these are in the organ that governs all life processes. Moreover, a lot of brain tumor types were observed, but only one main diagnostic method was used - histopathology, for which preparation of sample was long. Consequently, a new, quicker diagnostic method is needed. In this paper, FT-Raman spectra of brain tissues were analyzed by Principal Component Analysis (PCA), Hierarchical Cluster Analysis (HCA), four different machine learning (ML) algorithms to show possibility of differentiating between glioblastoma G4 and meningiomas, as well as two different types of meningiomas (atypical and angiomatous)...
February 8, 2024: Nanomedicine: Nanotechnology, Biology, and Medicine
https://read.qxmd.com/read/38341009/multifunctional-nanocoatings-with-synergistic-controlled-release-of-zinc-ions-and-cytokines-for-precise-modulation-of-vascular-intimal-reconstruction
#9
JOURNAL ARTICLE
Jianying Tan, Huanran Wang, Sainan Liu, Li Li, Hengquan Liu, Tao Liu, Junying Chen
Vascular stent implantation remains the major therapeutic method for cardiovascular diseases currently. We here introduced crucial biological functional biological function factors (SDF-1α, VEGF) and vital metal ions (Zn2+ ) into the stent surface to explore their synergistic effect in the microenvironment. The combination of the different factors is known to effectively regulate cellular inflammatory response and selectively regulate cell biological behavior. Meanwhile, in the implemented method, VEGF and Zn2+ were loaded into heparin and poly-l-lysine (Hep-PLL) nanoparticles, ensuring a controlled release of functional molecules with a multi-factor synergistic effect and excellent biological functions in vitro and in vivo...
February 8, 2024: Nanomedicine: Nanotechnology, Biology, and Medicine
https://read.qxmd.com/read/38295913/single-dose-thermoresponsive-dexamethasone-prodrug-completely-mitigates-joint-pain-for-15-weeks-in-a-murine-model-of-osteoarthritis
#10
JOURNAL ARTICLE
Ningrong Chen, Xin Wei, Gang Zhao, Zhenshan Jia, Xin Fu, Haochen Jiang, Xiaoke Xu, Zhifeng Zhao, Purva Singh, Samantha Lessard, Miguel Otero, Mary B Goldring, Steven R Goldring, Dong Wang
In this study, we aimed to assess the analgesic efficacy of a thermoresponsive polymeric dexamethasone (Dex) prodrug (ProGel-Dex) in a mouse model of osteoarthritis (OA). At 12 weeks post model establishment, the OA mice received a single intra-articular (IA) injection of ProGel-Dex, dose-equivalent Dex, or Saline. Comparing to Saline and Dex controls, ProGel-Dex provided complete and sustained pain relief for >15 weeks according to incapacitance tests. In vivo optical imaging confirmed the continuous presence of ProGel-Dex in joints for 15 weeks post-injection...
January 29, 2024: Nanomedicine: Nanotechnology, Biology, and Medicine
https://read.qxmd.com/read/38295912/new-graphene-containing-pharmaceutical-formulations-for-infrared-lamps-based-phototherapy-of-skin-cancer-in-vitro-validation-and-ex-vivo-human-skin-permeation
#11
JOURNAL ARTICLE
Filipa A L S Silva, Soraia Pinto, Susana G Santos, Fernão D Magalhães, Bruno Sarmento, Artur M Pinto
Basal cell carcinoma (BCC) is the most common form of human cancer, and treatment usually involves surgery, with alternative strategies being need. We propose the use of carbopol hydrogels (HG) for topical administration of nanographene oxide (GOn) and partially-reduced nanographene oxide (p-rGOn) for photothermal therapy (PTT) of BCC. GOn and p-rGOn into the HG present lateral sizes ~200 nm, being stable for 8 months. After 20 min irradiation with an infrared (IR) photothermal therapy lamp source (15...
January 29, 2024: Nanomedicine: Nanotechnology, Biology, and Medicine
https://read.qxmd.com/read/38199451/therapeutic-potential-of-combating-cancer-by-restoring-wild-type-p53-through-mrna-nanodelivery
#12
REVIEW
Divya Kamath, Tomoo Iwakuma, Stefan H Bossmann
Among the tumor suppressor genes, TP53 is the most frequently mutated in human cancers, and most mutations are missense mutations causing production of mutant p53 (mutp53) proteins. TP53 mutations not only results in loss of function (LOH) as a transcription factor and a tumor suppressor, but also gain wild-type p53 (WTp53)-independent oncogenic functions that enhance cancer metastasis and progression (Yamamoto and Iwakuma, 2018; Zhang et al., 2022). TP53 has extensively been studied as a therapeutic target as well as for drug development and therapies, however with limited success...
January 8, 2024: Nanomedicine: Nanotechnology, Biology, and Medicine
https://read.qxmd.com/read/38199450/a-pegylated-liposomal-formulation-of-prochlorperazine-that-limits-brain-exposure-but-retains-dynamin-ii-activity-a-potential-adjuvant-therapy-for-cancer-patients-receiving-chemotherapeutic-mabs
#13
JOURNAL ARTICLE
Christopher N Subasic, Fiona Simpson, Rodney F Minchin, Lisa M Kaminskas
Anti-cancer monoclonal antibodies often fail to provide therapeutic benefit in receptor-positive patients due to rapid endocytosis of antibody-bound cell surface receptors. High dose co-administration of prochlorperazine (PCZ) inhibits endocytosis and sensitises tumours to mAbs by inhibiting dynamin II but can also introduce neurological side effects. We examined the potential to use PEGylated liposomal formulations of PCZ (LPCZ) to retain the anti-cancer effects of PCZ, but limit brain uptake. Uncharged liposomes showed complete drug encapsulation and pH-dependent drug release, but cationic liposomes showed limited drug encapsulation and lacked pH-dependent drug release...
January 8, 2024: Nanomedicine: Nanotechnology, Biology, and Medicine
https://read.qxmd.com/read/38158147/improved-pharmacokinetics-and-enhanced-efficacy-of-the-vancomycin-derivative-fu002-using-a-liposomal-nanocarrier
#14
JOURNAL ARTICLE
Julia Werner, Florian Umstätter, Tobias Hertlein, Barbro Beijer, Christian Kleist, Eric Mühlberg, Stefan Zimmermann, Uwe Haberkorn, Knut Ohlsen, Gert Fricker, Walter Mier, Philipp Uhl
Antibiotic resistance still represents a global health concern which diminishes the pool of effective antibiotics. With the vancomycin derivative FU002, we recently reported a highly potent substance active against Gram-positive bacteria with the potential to overcome vancomycin resistance. However, the translation of its excellent antimicrobial activity into clinical efficiency could be hampered by its rapid elimination from the blood stream. To improve its pharmacokinetics, we encapsulated FU002 in PEGylated liposomes...
December 27, 2023: Nanomedicine: Nanotechnology, Biology, and Medicine
https://read.qxmd.com/read/38158146/chemosensitization-of-tumors-via-simultaneous-delivery-of-stat3-inhibitor-and-doxorubicin-through-hpma-copolymer-based-nanotherapeutics-with-ph-sensitive-activation
#15
JOURNAL ARTICLE
M Kovář, V Šubr, K Běhalová, M Studenovský, D Starenko, J Kovářová, P Procházková, T Etrych, L Kostka
We synthesized three novel STAT3 inhibitors (S3iD1-S3iD3) possessing oxoheptanoic residue enabling linkage to HPMA copolymer carrier via a pH-sensitive hydrazone bond. HPMA copolymer conjugates bearing doxorubicin (Dox) and our STAT3 inhibitors were synthesized to evaluate the anticancer effect of Dox and STAT3 inhibitor co-delivery into tumors. S3iD1-3 and their copolymer-bound counterparts (P-S3iD1-P-S3iD3) showed considerable in vitro cytostatic activities in five mouse and human cancer cell lines with IC50 ~0...
December 27, 2023: Nanomedicine: Nanotechnology, Biology, and Medicine
https://read.qxmd.com/read/38061449/membrane-cholesterol-enrichment-and-folic-acid-functionalization-lead-to-increased-accumulation-of-erythrocyte-derived-optical-nano-constructs-within-the-ovarian-intraperitoneal-tumor-implants-in-mice
#16
JOURNAL ARTICLE
Chi-Hua Lee, Jenny Mac, Taylor Hanley, Shamima Zaman, Raviraj Vankayala, Bahman Anvari
Cytoreductive surgery remains as the gold standard to treat ovarian cancer, but with limited efficacy since not all tumors can be intraoperatively visualized for resection. We have engineered erythrocyte-derived nano-constructs that encapsulate the near infrared (NIR) fluorophore, indocyanine green (ICG), as optical probes for NIR fluorescence imaging of ovarian tumors. Herein, we have enriched the membrane of these nano-constructs with cholesterol, and functionalized their surface with folic acid (FA) to target the folate receptor-α...
December 5, 2023: Nanomedicine: Nanotechnology, Biology, and Medicine
https://read.qxmd.com/read/38056586/integrating-osteoimmunology-and-nanoparticle-based-drug-delivery-systems-for-enhanced-fracture-healing
#17
REVIEW
Baixue Xiao, Emmanuela Adjei-Sowah, Danielle S W Benoit
Fracture healing is a complex interplay of molecular and cellular mechanisms lasting from days to weeks. The inflammatory phase is the first stage of fracture healing and is critical in setting the stage for successful healing. There has been growing interest in exploring the role of the immune system and novel therapeutic strategies, such as nanoparticle drug delivery systems in enhancing fracture healing. Advancements in nanotechnology have revolutionized drug delivery systems to the extent that they can modulate immune response during fracture healing by leveraging unique physiochemical properties...
December 4, 2023: Nanomedicine: Nanotechnology, Biology, and Medicine
https://read.qxmd.com/read/38052371/customizing-biomimetic-surface-attributes-of-dendritic-lipopeptide-nanoplatforms-for-extended-circulation
#18
JOURNAL ARTICLE
Jingjing Wei, Yin Zhou, Yiyan He, Wentao Zhao, Zhiqiang Luo, Jian Yang, Hongli Mao, Zhongwei Gu
The pressing demand for innovative approaches to create delivery systems with heightened drug loading and prolonged circulation has spurred numerous efforts, yielding some successes but accompanied by constraints. Our study proposes employing dendritic lipopeptide with precisely balanced opposing charges to extend blood residency for biomimetic nanoplatforms. Neutrally mixed-charged zwitterionic nanoparticles (NNPs) achieved a notable 19 % simvastatin loading content and kept stable even after one-month storage at 4 °C...
December 3, 2023: Nanomedicine: Nanotechnology, Biology, and Medicine
https://read.qxmd.com/read/38007069/defined-covalent-attachment-of-three-cancer-drugs-to-dna-origami-increases-cytotoxicity-at-nanomolar-concentration
#19
JOURNAL ARTICLE
Natalia Navarro, Anna Aviñó, Òscar Domènech, Jordi H Borrell, Ramon Eritja, Carme Fàbrega
DNA nanostructures have captured great interest as drug delivery vehicles for cancer therapy. Despite rapid progress in the field, some hurdles, such as low cellular uptake, low tissue specificity or ambiguous drug loading, remain unsolved. Herein, well-known antitumor drugs (doxorubicin, auristatin, and floxuridine) were site-specifically incorporated into DNA nanostructures, demonstrating the potential advantages of covalently linking drug molecules via structural staples instead of incorporating the drugs by noncovalent binding interactions...
November 23, 2023: Nanomedicine: Nanotechnology, Biology, and Medicine
https://read.qxmd.com/read/38007068/dual-targeted-nanoparticles-with-removing-ros-inside-and-outside-mitochondria-for-acute-kidney-injury-treatment
#20
JOURNAL ARTICLE
Mengmeng Zhao, Jialing Guo, Chaoying Tian, Mei Yan, Yingying Zhou, Chenxin Liu, Mengxue Pang, Bin Du, Genyang Cheng
Mitochondrial oxidative stress and inflammation are the main pathological features of acute kidney injury (AKI). However, systemic toxicity of anti-inflammatory drugs and low bioavailability of antioxidants limit the treatment of AKI. Here, the lipid micelle nanosystem modified with l-serine was designed to improve treatment of AKI. The micelle kernels coating the antioxidant drug 4-carboxybutyl triphenylph-osphine bromide-modified curcumin (Cur-TPP) and quercetin (Que). In the cisplatin (CDDP)-induced AKI model, the nanosystem protected mitochondrial structure and improved renal function...
November 23, 2023: Nanomedicine: Nanotechnology, Biology, and Medicine
journal
journal
40854
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.